Ozempic is generally effective for weight loss, but it’s not FDA-approved for that purpose, and it carries real side effects and risks worth understanding before you start. The active ingredient, semaglutide, is the same drug found in Wegovy, which is approved for weight management at a higher dose (2.4 mg weekly versus Ozempic’s maximum of 2 mg). When prescribed off-label for weight loss, Ozempic works, but the safety picture depends on your health history, how long you take it, and how your body responds.
How Ozempic Causes Weight Loss
Semaglutide mimics a hormone your gut naturally produces after eating. It works on two fronts: it slows how quickly your stomach empties, so food sits longer and you feel full faster, and it acts on appetite-regulating pathways in the brain to reduce hunger and cravings. People on semaglutide tend to eat less overall and show less preference for high-fat, calorie-dense foods. The combination of reduced appetite and slower digestion is what drives the weight loss, not any increase in metabolism or calorie burning.
In a two-year clinical trial (the STEP 5 study), participants on semaglutide lost an average of 15.2% of their body weight, compared to 2.6% in the placebo group. Over three-quarters of people on the drug lost at least 5% of their starting weight. These results held steady through the full 104 weeks, suggesting the effect doesn’t wear off as long as you keep taking it.
Common Side Effects Are Mostly Digestive
The most predictable downside is gastrointestinal discomfort. In the STEP 5 trial, 82% of people on semaglutide reported digestive side effects, compared to 54% on placebo. Nausea, diarrhea, vomiting, and constipation are the big four. Most of these episodes were rated mild to moderate and tended to be worst during the dose-escalation phase, when your body is adjusting to increasing amounts of the drug. They often improve over weeks or months, though some people find them persistent enough to stop treatment.
The gradual dose increase that doctors use when starting semaglutide exists specifically to minimize these effects. Skipping ahead to a higher dose, or obtaining the drug without medical supervision, increases the likelihood of more severe nausea and vomiting.
Serious Risks to Know About
Semaglutide carries a boxed warning, the FDA’s most serious label category, for thyroid tumors. In animal studies, the drug caused thyroid C-cell tumors in rodents. Whether this translates to humans isn’t fully settled, but anyone with a personal or family history of medullary thyroid carcinoma, or a condition called Multiple Endocrine Neoplasia syndrome type 2, should not take semaglutide at all.
Acute pancreatitis occurred in roughly 0.24% of semaglutide-treated patients across clinical trials. That’s a low rate, but pancreatitis is a serious, painful condition that requires immediate medical attention. For comparison, pancreatitis occurred at 0.07% with another diabetes drug in the same analysis. If you have a history of pancreatitis, this risk warrants a careful conversation with your doctor.
The FDA label also now notes that Ozempic is not recommended for people with severe gastroparesis, a condition where the stomach already empties too slowly. Since semaglutide further delays gastric emptying, it can worsen symptoms significantly. Postmarketing reports have also flagged cases of intestinal obstruction, severe constipation, and fecal impaction, though these appear to be uncommon.
Muscle Loss Is a Real Concern
When you lose weight on semaglutide, not all of it comes from fat. A systematic review of clinical trials found that while fat mass accounts for most of the loss, reductions in lean mass (which includes muscle) ranged from nearly 0% to 40% of total weight lost, depending on the study. Some participants maintained their muscle mass well; others lost a meaningful amount.
This matters because losing muscle can lower your metabolic rate, reduce physical strength, and increase injury risk, particularly for older adults. Resistance training and adequate protein intake during treatment can help preserve lean mass, and most clinicians who prescribe semaglutide for weight loss now emphasize both as part of the plan. The drug alone, without attention to exercise and nutrition, carries a higher chance of unfavorable body composition changes.
Ozempic vs. Wegovy for Weight Loss
Ozempic and Wegovy contain the same active ingredient, but they’re approved for different uses. Ozempic is FDA-approved for managing type 2 diabetes, improving kidney and cardiovascular health in people with type 2 diabetes, and reducing cardiovascular risk in that population. Wegovy is the version approved for weight management in adults and children 12 and older, as well as for cardiovascular risk reduction in adults with obesity or overweight who have heart disease.
The dosing differs too. Wegovy’s maximum maintenance dose is 2.4 mg per week, while Ozempic tops out at 2 mg. When a doctor prescribes Ozempic specifically for weight loss, they’re prescribing it off-label, which is legal and common in medicine but means the drug wasn’t tested and approved through the FDA for that specific purpose. Wegovy was studied in dedicated weight-loss trials with a tailored dose-escalation schedule. You also shouldn’t take both, or combine either with another drug in the same class.
Who Should Avoid Semaglutide
Beyond the thyroid cancer and pancreatitis concerns, semaglutide is contraindicated if you have a known allergy to the drug or any of its inactive ingredients. People with severe gastroparesis should avoid it. And if you’re planning to become pregnant, the current recommendation is to stop semaglutide at least two months before trying to conceive, since the drug’s effects on fetal development haven’t been adequately studied in humans.
People who are only mildly overweight and have no weight-related health conditions may find that the risk profile doesn’t justify the benefits. The clinical trials that established semaglutide’s safety and effectiveness enrolled people with obesity (BMI of 30 or higher) or those with a BMI of 27 or higher who also had at least one weight-related condition like high blood pressure, high cholesterol, or type 2 diabetes. If you fall outside that range, the benefit-to-risk math changes.
What Happens When You Stop
Weight regain after stopping semaglutide is well documented. The drug suppresses appetite for as long as you take it, but those effects fade once you stop. Most people regain a significant portion of lost weight within a year of discontinuation, which is why many doctors frame semaglutide as a long-term or even indefinite treatment rather than a short course. This raises practical questions about cost, ongoing side effect exposure, and whether you’re comfortable with the idea of staying on an injectable medication for years.
The two-year STEP 5 data showed sustained weight loss at 104 weeks for people who kept taking the drug, which is encouraging for long-term use. But the longest safety data available still covers a relatively limited window. Semaglutide has been used for diabetes since 2017, so there’s a reasonable track record, but decades-long data on its use purely for weight loss in otherwise healthy people doesn’t yet exist.